Kidney Transplantation
504
33
46
311
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
82 trials with published results (16%)
Research Maturity
311 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.7%
39 terminated out of 504 trials
88.9%
+2.4% vs benchmark
33%
167 trials in Phase 3/4
26%
82 of 311 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 311 completed trials
Clinical Trials (504)
Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
MRI Technical Development and Applications in Kidney Disease
Shingrix in Renal Transplant Recipients
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients
Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.
Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)
A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation
Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During Chronic AntiBody-Mediated Rejection in Kidney Transplantation.
Kidney Transplant Improvement Through New Exercise Training to Increase Capacity
HLA-Identical Sibling Renal Transplant Tolerance
REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients
Tolerance by Engaging Antigen During Cellular Homeostasis
A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)
A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA)
Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.